Y. Pierre Gobin
| Y. Pierre Gobin, MD | |
|---|---|
| Fields | Physician & Neurosurgeon |
| Institutions | Weill Medical College; New York Presbyterian Medical Center |
| Known for | Research in neuroscience & neurosurgery |
Y. Pierre Gobin (born 1957) is a French-born American physician who is an expert in the field of interventional neuroradiology and a pioneer in endovascular treatment of cerebral aneurysms. He is one of the inventors of the Concentric MERCI Retriever, a device for removing blood clots in the brain that cause stroke. He is also one of the developers of intra-arterial chemotherapy for the treatment of retinoblastoma, a rare genetic cancer that affects the eyes of babies and children who inherit it.
Gobin is the director of Interventional Neuroradiology at New York-Presbyterian Hospital Weill Cornell Medical Center and professor of radiology in neurological surgery at Weill Cornell Medical College.
Gobin was born in Paris in 1957 and grew up in the countryside outside Paris. He returned Paris to attend medical school.
Gobin completed his medical degree, internship and radiology residency at the University of Paris, France in 1988. He trained in interventional neuroradiology at Hospital Lariboisiere in Paris, where he performed the first Guglielmi Detachable Coil (GDC) embolization in France, in a patient with a cerebral aneurysm.
Gobin came to the United States in 1992, when he was recruited by the Division of Interventional Neuroradiology of the University of California at Los Angeles (UCLA) based on his experience with GDC embolization, which had been invented at UCLA. He was on the faculty at UCLA for nine years, during which time he continued clinical evaluation of GDC technology.
At UCLA, Gobin was part of the team that invented an new device to remove blood clots from the brain, which cause ischemic stroke. The device was conceived in 1995 after a frustrating experience in the operating room in which surgeons were unable to reopen a blood vessel blocked by a clot. In 1999 Gobin became Medical Director of the newly founded Concentric Medical, where he continued his development of the device. In 2001 the first patient was restored to health when a blood clot was successfully removed during a clinical trial. The device, which by then had been named the Mechanical Embolus Removal in Cerebral Ischemia, or MERCI for short, received FDA approval in 2004.
...
Wikipedia